Chilly Mazarin, France

Samir Messaoudi

USPTO Granted Patents = 6 

 

Average Co-Inventor Count = 8.1

ph-index = 1

Forward Citations = 3(Granted Patents)


Location History:

  • Palaiseau, FR (2012)
  • Chilly Mazarin, FR (2020 - 2022)
  • Chatenay-Malabry, FR (2020 - 2022)

Company Filing History:


Years Active: 2012-2025

Loading Chart...
Loading Chart...
6 patents (USPTO):Explore Patents

Title: Samir Messaoudi: Innovator in Cancer Treatment

Introduction

Samir Messaoudi is a notable inventor based in Chilly Mazarin, France. He has made significant contributions to the field of medicine, particularly in cancer treatment. With a total of 6 patents to his name, Messaoudi's work focuses on developing innovative compounds that aim to improve therapeutic outcomes for cancer patients.

Latest Patents

One of Messaoudi's latest patents is for Madrasin-derivative compounds, which are designed for treating cancer. This invention relates to new compounds that serve as medicaments, specifically aimed at enhancing the presentation of Pioneer Translation Products (PTPs)-derived antigens by cancer cells. The invention also discusses methods for treating diseases, particularly cancer, and preventing metastasis or recurrence. Another significant patent involves dizocilpine derivatives as peripheral NMDA receptor antagonists, showcasing his diverse research interests.

Career Highlights

Throughout his career, Messaoudi has worked with prestigious organizations such as the Centre National de la Recherche Scientifique and the Institut National de la Santé et de la Recherche Médicale. His experience in these institutions has allowed him to contribute to groundbreaking research in the medical field.

Collaborations

Messaoudi has collaborated with notable colleagues, including Mouad Alami and Jean-Daniel Brion. These partnerships have further enriched his research and innovation efforts.

Conclusion

Samir Messaoudi stands out as a dedicated inventor whose work in cancer treatment has the potential to make a significant impact on patient care. His innovative compounds and collaborative efforts reflect his commitment to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…